Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -157,128 | -131,643 | -81,035 | -16,661 | -230,026 |
| Depreciation Amortization | 2,388 | 1,752 | 1,180 | 594 | 2,630 |
| Income taxes - deferred | -1,621 | -7,550 | -7,991 | -3,856 | -26,049 |
| Accounts receivable | -42,753 | 6,936 | 9,355 | 3,466 | -30,218 |
| Accounts payable and accrued liabilities | 310 | -411 | 970 | 4,383 | 6,798 |
| Other Working Capital | -48,725 | 10,272 | 14,923 | -1,551 | -15,710 |
| Other Operating Activity | 109,218 | 35,947 | -24,294 | -20,257 | 59,197 |
| Operating Cash Flow | $-138,311 | $-84,697 | $-86,892 | $-33,882 | $-233,378 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -687 | -473 | -279 | -229 | -3,430 |
| Purchase Sale Intangibles | N/A | -1,708 | -1,648 | -889 | -2,946 |
| Other Investing Activity | 0 | -1,918 | -1,858 | -1,219 | -3,243 |
| Investing Cash Flow | $-687 | $-2,391 | $-2,137 | $-1,448 | $-6,673 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 115,597 | 114,490 | N/A | N/A | 49,591 |
| Debt Repayment | -118,304 | -118,070 | N/A | N/A | N/A |
| Common Stock Issued | 6,130 | 6,192 | N/A | N/A | 778 |
| Other Financing Activity | -4,320 | -757 | -510 | -258 | 217,025 |
| Financing Cash Flow | $-897 | $1,855 | $-510 | $-258 | $267,394 |
| Exchange Rate Effect | -208 | -451 | -227 | -82 | 6 |
| Beginning Cash Position | 466,544 | 466,544 | 466,544 | 466,544 | 439,195 |
| End Cash Position | 326,441 | 380,860 | 376,778 | 430,874 | 466,544 |
| Net Cash Flow | $-140,103 | $-85,684 | $-89,766 | $-35,670 | $27,349 |
| Free Cash Flow | |||||
| Operating Cash Flow | -138,311 | -84,697 | -86,892 | -33,882 | -233,378 |
| Capital Expenditure | -687 | -473 | -279 | -229 | -3,430 |
| Free Cash Flow | -138,998 | -85,170 | -87,171 | -34,111 | -236,808 |